1. Yang, Fang, Begemann, Anais, Reichhart, Nadine, Strauß, Olaf, Rauch, Anita. 2024. Missense variants in ANO4 cause sporadic encephalopathic or familial epilepsy with evidence for a dominant-negative effect. In American journal of human genetics, 111, 1184-1205. doi:10.1016/j.ajhg.2024.04.014. https://pubmed.ncbi.nlm.nih.gov/38744284/
2. Tu, Longlong, Bean, Jonathan C, He, Yang, He, Yanlin, Xu, Yong. 2023. Anoctamin 4 channel currents activate glucose-inhibited neurons in the mouse ventromedial hypothalamus during hypoglycemia. In The Journal of clinical investigation, 133, . doi:10.1172/JCI163391. https://pubmed.ncbi.nlm.nih.gov/37261917/
3. Al Sharie, Ahmed H, Al Zu'bi, Yazan O, El-Elimat, Tamam, Al Malkawi, Abubaker A, Alali, Feras Q. 2023. ANO4 Expression Is a Potential Prognostic Biomarker in Non-Metastasized Clear Cell Renal Cell Carcinoma. In Journal of personalized medicine, 13, . doi:10.3390/jpm13020295. https://pubmed.ncbi.nlm.nih.gov/36836529/
4. Maniero, Carmela, Scudieri, Paolo, Haris Shaikh, Lalarukh, Galietta, Luis J V, Brown, Morris J. 2019. ANO4 (Anoctamin 4) Is a Novel Marker of Zona Glomerulosa That Regulates Stimulated Aldosterone Secretion. In Hypertension (Dallas, Tex. : 1979), 74, 1152-1159. doi:10.1161/HYPERTENSIONAHA.119.13287. https://pubmed.ncbi.nlm.nih.gov/31564164/
5. Maniero, Carmela, Zhou, Junhua, Shaikh, Lalarukh H, Galietta, Louis J, Brown, Morris J. . Role of ANO4 in regulation of aldosterone secretion in the zona glomerulosa of the human adrenal gland. In Lancet (London, England), 385 Suppl 1, S62. doi:10.1016/S0140-6736(15)60377-4. https://pubmed.ncbi.nlm.nih.gov/26312884/